Skip to main content
M
Doctor-Reviewed Content Verified Hospital Data Updated Medical Information Patient-First Guidance Not for Emergencies — Call 911

Laparoscopic Rectopexy — Cost, Top Hospitals & Success Rates | MyMedicPlus

Updated: 2026-06-26
Ad — after-intro

Quick Facts

Procedure Type
Laparoscopic Colorectal / Pelvic Floor Surgery
Target Condition
Full-Thickness Rectal Prolapse
Surgical Duration
1.5–3 hours
Anaesthesia
General anaesthesia
Hospital Stay
2–4 days
Recovery to Normal Activities
4–6 weeks
Recurrence Rate
2–10% at 5 years (laparoscopic approach)
Specialty
Colorectal Surgery / General Surgery

Overview

Laparoscopic rectopexy (also written as laparoscopic retopexy) is a minimally invasive surgical procedure performed to treat full-thickness rectal prolapse — a condition in which the entire wall of the rectum protrudes through the anal canal, turning inside out (intussuscepting) and protruding externally as a visible red tissue mass. The operation corrects the prolapse by mobilising the rectum from its surrounding attachments and anchoring it securely to the sacrum (posterior pelvic wall) using sutures, mesh, or a combination of both, restoring normal anatomy and function.

Before the widespread adoption of laparoscopy in the 1990s, rectal prolapse repair was predominantly performed through open abdominal or perineal approaches. Perineal operations (Delorme procedure, Altemeier perineal rectosigmoidectomy) offer lower physiological stress and can be performed under spinal anaesthesia in frail elderly patients, but carry significantly higher recurrence rates of 10–30%. Abdominal rectopexy — now predominantly performed laparoscopically — provides the lowest long-term recurrence rates (2–10%) and is the preferred approach for medically fit patients.

Two main laparoscopic abdominal techniques are in current use: posterior suture rectopexy (Wells or Ripstein modification) and ventral mesh rectopexy (DéRoover-D'Hoore technique). The ventral approach, which attaches mesh to the anterior rectal wall without posterior dissection of the mesorectal plane, is increasingly favoured because it preserves the autonomic nerves supplying the bladder and sexual organs, reduces post-operative constipation, and appears equally effective at preventing recurrence.

Laparoscopic rectopexy is also applicable to internal rectal intussusception (incomplete prolapse), solitary rectal ulcer syndrome associated with chronic straining, and, in selected cases, obstructed defaecation syndrome where posterior rectal prolapse mechanically impedes stool passage.

Conditions Treated

Laparoscopic rectopexy addresses a spectrum of posterior pelvic floor disorders centred on loss of normal rectal fixation:

  • Full-Thickness Rectal Prolapse (External Prolapse): The primary indication. The entire thickness of the rectal wall prolapses through the anal canal, visible as a red, concentric-ringed mucosal mass protruding several centimetres beyond the anus. Symptoms include mucous and faecal soiling, faecal urgency and incontinence, a sensation of incomplete evacuation, and significant psychological distress. Left untreated, prolapse worsens progressively and may cause incarceration requiring emergency surgery.
  • Internal Rectal Intussusception (Incomplete Rectal Prolapse): The rectal wall telescopes inward but does not emerge through the anal canal. Patients present with severe obstructed defaecation, straining, and a feeling of rectal blockage. High-grade intussusception (Oxford Grade III–IV) may benefit from rectopexy when conservative measures fail.
  • Solitary Rectal Ulcer Syndrome (SRUS): Chronic straining against an intussuscepting rectum causes traumatic ulceration of the anterior rectal wall, with passage of blood and mucous. Rectopexy corrects the underlying prolapse and allows ulcer healing in the majority of cases.
  • Obstructed Defaecation Syndrome (ODS) with Posterior Compartment Prolapse: In the context of multi-compartment pelvic floor prolapse, laparoscopic ventral mesh rectopexy addresses the posterior compartment component (rectocoele, enterocoele, rectal intussusception) while restoring normal rectal fixation and improving defaecatory function.
  • Recurrent Rectal Prolapse After Perineal Repair: Patients who have previously undergone a perineal procedure (Delorme or Altemeier) and suffered recurrence are well served by laparoscopic abdominal rectopexy, which addresses the fundamental lack of rectal fixation that perineal approaches do not correct.

Patient selection requires careful clinical assessment including proctoscopy, defaecation proctography or dynamic MRI proctogram, and anorectal physiology testing (manometry, pudendal nerve terminal motor latency) to characterise the full extent of pelvic floor dysfunction before surgery.

Patient Eligibility

The majority of medically fit patients with full-thickness rectal prolapse are candidates for laparoscopic rectopexy. The key decision is between an abdominal (laparoscopic) and a perineal approach, guided primarily by the patient's physiological reserve and anaesthetic fitness.

Candidates well suited to laparoscopic rectopexy include:

  • Medically fit patients with full-thickness external rectal prolapse who can tolerate general anaesthesia and pneumoperitoneum (CO2 insufflation) for 2–3 hours
  • Younger and middle-aged patients for whom the lower recurrence rate of abdominal repair justifies the greater procedural complexity
  • Patients with significant faecal incontinence in whom rectopexy may improve continence by reducing the prolapse-related stretch injury to the internal and external anal sphincters
  • Patients with constipation-predominant symptoms who may particularly benefit from ventral mesh rectopexy, which avoids posterior rectal dissection and the associated risk of worsening constipation
  • Patients with recurrent prolapse after prior perineal procedures

Factors favouring perineal repair (Delorme or Altemeier procedure) over laparoscopic rectopexy:

  • Advanced age (typically >75–80 years) with significant cardiorespiratory comorbidities making general anaesthesia high risk
  • Significant frailty — perineal procedures can be performed under spinal or even local anaesthesia with sedation
  • Severe cardiopulmonary disease or prior major abdominal surgery with extensive adhesions complicating laparoscopic access
  • Patient preference for a shorter operative time and faster return to pre-morbid status even at the cost of higher recurrence risk

Pre-operative work-up includes: clinical examination and proctoscopy, defaecation proctography or dynamic MRI proctogram to characterise prolapse grade and associated pelvic floor defects, anorectal manometry and pudendal nerve studies to assess sphincter function, colonoscopy or CT colonography in patients >50 years or with suspicious symptoms, and standard pre-operative bloods and anaesthetic assessment.

Surgical Techniques

Several laparoscopic abdominal rectopexy techniques have been developed, differing primarily in the extent of rectal mobilisation, the use of mesh, and the fixation site.

1. Posterior Suture Rectopexy (Wells/Orr-Loygue Technique)
The rectum is fully mobilised posteriorly in the mesorectal plane down to the pelvic floor, then sutured bilaterally to the presacral fascia over the sacral promontory using non-absorbable sutures. This technique straightens and anchors the rectum without mesh, avoiding the rare but serious complication of mesh-related erosion or infection. Recurrence rates are 2–10% at 5 years. A recognised disadvantage is post-operative constipation in 30–40% of patients due to division of the lateral rectal ligaments during posterior mobilisation.

2. Posterior Mesh Rectopexy (Ripstein Procedure, Laparoscopic Version)
A modification of posterior rectopexy in which prosthetic mesh (polypropylene or polyester) is sutured posteriorly around the mobilised rectum and fixed to the sacrum, providing additional mechanical support. This approach carries a similar recurrence profile to suture rectopexy but introduces mesh-related risks including stricture of the mesh wrap and erosion into the rectum.

3. Laparoscopic Ventral Mesh Rectopexy (D’Hoore Technique)
The currently favoured technique at most high-volume centres. Unlike posterior rectopexy, the posterior mesorectal plane is not entered. Instead, the peritoneum is opened anteriorly in the rectovaginal (or rectovesical in men) space, and a strip of mesh is sutured to the anterior rectal wall and upper vagina (addressing coexisting vaginal vault descent), then fixed to the sacral promontory. This approach preserves all posterior autonomic nerve bundles, reduces post-operative constipation (compared to posterior techniques), and addresses multi-compartment pelvic floor prolapse in a single procedure. Published case series report recurrence rates of 2–5% at 3–5 years.

4. Robotic Ventral Mesh Rectopexy
Robotic platforms (da Vinci system) offer enhanced three-dimensional visualisation and articulated instrument movement in the confined pelvic space, facilitating precise dissection and mesh placement. Outcomes are comparable to laparoscopic ventral rectopexy with potentially lower conversion rates in obese patients or those with prior pelvic surgery.

5. Resection Rectopexy (Frykman-Goldberg Procedure)
Posterior rectopexy combined with sigmoid colectomy, indicated in patients with significant constipation and a redundant sigmoid colon. Removing the redundant bowel reduces constipation risk while rectopexy prevents prolapse recurrence. This is a more complex procedure with higher anastomotic leak risk and is reserved for carefully selected constipation-dominant patients.

Benefits

Laparoscopic rectopexy offers meaningful clinical advantages over both open abdominal and perineal approaches to rectal prolapse repair:

  • Lowest Recurrence Rate of All Repair Methods: Abdominal rectopexy achieves 5-year recurrence rates of 2–10%, substantially lower than perineal procedures (10–30%). This superiority reflects the fundamental correction of the underlying anatomical defect — restoring rectal fixation — rather than simply excising the prolapsed tissue.
  • Minimally Invasive Advantages: Compared to open abdominal rectopexy, laparoscopic surgery significantly reduces post-operative pain, blood loss, wound complications, time to bowel function recovery, and hospital length of stay. Most patients resume diet and ambulation within 24–48 hours. Published RCT data (PROSPER trial, Senapati et al., 2013) confirm equivalent oncological and prolapse outcomes with the reduced morbidity profile expected of minimally invasive surgery.
  • Improved Continence: In patients with co-existing faecal incontinence — caused by pudendal nerve stretch injury from repeated prolapse — rectopexy restores the anorectal angle, reduces chronic sphincter stretch, and improves continence in 50–70% of affected patients. This is one of the most valued outcomes for patients who experience daily faecal soiling.
  • Preservation of Autonomic Nerves (Ventral Approach): The ventral mesh technique avoids posterior mesorectal dissection, preserving the hypogastric nerve plexus and pelvic splanchnic nerves that control bladder filling, sexual function, and bowel motility. This translates to lower rates of post-operative bladder dysfunction and sexual dysfunction compared to posterior techniques.
  • Multi-Compartment Correction: Ventral mesh rectopexy simultaneously addresses posterior compartment prolapse (rectum, posterior vaginal wall) in a single laparoscopic procedure, avoiding the need for staged perineal and abdominal repairs.
  • Early Return to Activities: Most patients are discharged within 2–4 days and return to sedentary work within 2–3 weeks. Full return to physical activities typically occurs at 4–6 weeks.

Risks and Complications

Laparoscopic rectopexy is a safe procedure with low mortality (<0.5%) when performed by experienced colorectal surgeons, but specific complications are recognised and should be discussed pre-operatively.

  • Post-Operative Constipation: The most common functional complication, particularly after posterior suture or mesh rectopexy with lateral ligament division. Reported in 30–40% of posterior rectopexy patients. Constipation arises from denervation of the rectum during dissection. The ventral mesh approach significantly reduces this risk (constipation worsening in <10%). Pre-existing constipation and bowel dysmotility are important risk factors.
  • Recurrence of Prolapse: Long-term recurrence occurs in 2–10% of laparoscopic abdominal rectopexy patients (versus 10–30% for perineal procedures). Recurrence risk is higher in patients with connective tissue disorders, previous pelvic irradiation, or inadequate sacral fixation at the initial operation.
  • Mesh-Related Complications: When mesh is used (particularly in ventral rectopexy), rare but serious complications include mesh erosion into the rectum or vagina (0.5–2%), mesh infection requiring removal, and mesh contraction causing stricture. Choice of mesh material (lightweight macroporous polypropylene or biological mesh) and careful placement technique minimise these risks.
  • Urinary Complications: Post-operative urinary retention occurs in 5–15% of patients, more commonly in elderly men. Injury to the autonomic nerve supply of the bladder during anterior rectal dissection can cause persistent bladder dysfunction; the ventral approach is protective against this complication.
  • Haemorrhage: Significant intra-operative bleeding from the sacral venous plexus occurs in less than 2% of cases. Presacral vessels, which retract when injured and are difficult to control, are the principal haemorrhage risk during posterior dissection.
  • Anastomotic Leak (Resection Rectopexy Only): When sigmoid resection is combined with rectopexy, anastomotic leak risk is 2–5%, as for any colorectal anastomosis. This is managed with a defunctioning loop ileostomy in selected high-risk patients.
  • Conversion to Open Surgery: Laparoscopic conversion to open surgery occurs in 2–5% of cases, typically due to adhesions from prior surgery, haemorrhage, or extreme obesity limiting visualisation.

Recovery and Follow-Up

Recovery from laparoscopic rectopexy follows an enhanced recovery pathway designed to restore bowel function and ambulation as rapidly as possible.

Immediate Post-Operative Period (Days 1–4): Patients are mobilised on the first post-operative day under physiotherapy supervision. Oral fluids are commenced within 6–12 hours of surgery; a light diet follows at 24 hours. An indwelling urinary catheter, inserted to protect against urinary retention, is typically removed at 24–48 hours. Regular analgesia (paracetamol, NSAIDs, low-dose oral opioids) is prescribed on a scheduled basis. Bowel function returns within 2–4 days; patients are not discharged until passing flatus and tolerating a normal diet. Hospital stay averages 2–4 days.

Early Recovery (Weeks 2–6): A clinic review at 2 weeks assesses wound healing, bowel function, and early functional outcomes (continence, defaecation frequency, urgency). Dietary advice centres on high-fibre intake, adequate hydration (2 litres daily), and regular use of stool softeners (macrogol/polyethylene glycol) to prevent constipation and straining — the latter being particularly important to protect the rectopexy fixation while it consolidates. Patients are advised to avoid heavy lifting (>5 kg) and high-impact activities for 6 weeks.

Subacute Recovery (Weeks 6–12): Return to work (sedentary) is typically possible at 2–3 weeks; return to manual occupations at 6–8 weeks. Pelvic floor physiotherapy is recommended at 4–6 weeks, particularly for patients with co-existing incontinence or obstructed defaecation. Biofeedback training significantly improves continence scores in patients with residual sphincter weakness.

Long-Term Follow-Up (Months 3–24): Clinical assessment at 3, 6, and 12 months evaluates prolapse recurrence, bowel function, continence, and quality of life using validated scoring tools (Cleveland Clinic Incontinence Score, Wexner Constipation Scale). Dynamic MRI proctogram at 6–12 months is obtained if symptoms suggest recurrence. Patients are counselled on maintaining healthy bowel habits — regular meals, high-fibre diet, adequate hydration — and avoiding prolonged straining as lifelong measures to reduce prolapse recurrence risk.

Cost Factors

The total cost of laparoscopic rectopexy varies based on surgical technique, mesh selection, country of treatment, and length of hospital stay.

  • Country and Healthcare Setting: In the United States, laparoscopic rectopexy costs USD 15,000–35,000 including surgeon fees, anaesthesia, hospital stay, and disposable laparoscopic instruments. In India at JCI-accredited hospitals, the procedure costs USD 2,500–6,000; in Thailand, USD 4,000–8,000; in Turkey, USD 3,000–7,000; in Malaysia, USD 4,000–9,000.
  • Technique Selection: Suture-only posterior rectopexy is less costly than ventral mesh rectopexy due to lower implant costs. Mesh type also affects cost: biological mesh (derived from porcine or bovine collagen) costs USD 1,500–4,000 per piece, compared to USD 100–400 for synthetic macroporous polypropylene mesh. Robotic-assisted rectopexy adds USD 2,000–5,000 in robotic time and disposable instrument costs.
  • Resection Rectopexy vs. Rectopexy Alone: Adding sigmoid colectomy and anastomosis increases operative time, instrument use, and post-operative monitoring requirements, adding USD 4,000–10,000 to total cost. In systems where defunctioning ileostomy is used, a second admission for stoma reversal adds further expense.
  • Hospital Length of Stay: Each additional day of hospitalisation adds USD 800–4,000 depending on healthcare system. Enhanced recovery protocols, now standard in most high-volume centres, reduce average length of stay to 2–3 days, substantially lowering total cost compared to historical stays of 5–7 days.
  • Pelvic Floor Physiotherapy: Post-operative pelvic floor rehabilitation adds USD 300–2,000 over 8–12 weeks, depending on session frequency and specialist availability. This is a clinically cost-effective investment for patients with co-existing incontinence.
  • Insurance Coverage: When performed for symptomatic full-thickness external rectal prolapse confirmed clinically and on proctogram, laparoscopic rectopexy is covered by most private insurers and national health programmes. Internal intussusception and obstructed defaecation indications may require additional documentation.

Alternatives to Laparoscopic Rectopexy

The management of rectal prolapse encompasses both non-operative palliation and a range of surgical approaches, each tailored to the patient's physiological status, prolapse severity, and functional goals.

Non-Surgical Management (Palliation in High-Risk Patients):

  • Pelvic Floor Physiotherapy and Biofeedback: For patients with incomplete internal intussusception or mild obstructed defaecation, a structured programme of pelvic floor rehabilitation, defaecatory manoeuvres, and biofeedback training can improve symptoms substantially and defer or avoid surgery in selected patients. Surgery is generally unavoidable for full-thickness external prolapse.
  • Dietary and Bowel Habit Modification: High-fibre diet, adequate hydration, laxatives, and avoidance of prolonged straining reduce the mechanical forces driving prolapse progression. While unable to reverse established prolapse, these measures improve bowel symptoms and quality of life.
  • Pessary or Manual Reduction: For frail patients in whom any surgery is prohibitively risky, manual reduction of the prolapse after each episode and a mechanical perineal support (ring pessary modified for prolapse) can partially control symptoms. These are temporary measures with significant patient burden.

Surgical Alternatives:

  • Perineal Rectosigmoidectomy (Altemeier Procedure): Full-thickness excision of the prolapsed rectal segment and sigmoid colon via the perineal route, followed by colo-anal anastomosis. Performed under spinal anaesthesia, this is the preferred approach for elderly or frail patients who cannot tolerate general anaesthesia. Recurrence rates of 15–30% at 5 years are substantially higher than abdominal rectopexy.
  • Delorme Procedure: Mucosal stripping of the prolapsed segment with plication of the underlying muscle, performed entirely through the perineum. Suitable for shorter prolapses and very elderly patients. Recurrence is high (10–25%) but re-do Delorme procedures are feasible and well tolerated.
  • STARR (Stapled Transanal Rectal Resection): Circular stapling devices deployed transanally resect the internal intussusception component, primarily addressing obstructed defaecation rather than full external prolapse. Risk of serious complications including rectovaginal fistula and severe urgency has limited its adoption.
  • Open Abdominal Rectopexy: The laparoscopic rectopexy techniques described above were derived from open surgery. Open rectopexy is now rarely performed except where laparoscopic access is not feasible (severe adhesions, extreme obesity, or absence of laparoscopic expertise). Outcomes are equivalent but recovery is substantially longer.

Selection of the optimal repair strategy requires multidisciplinary input from colorectal surgeons, urogynaecologists (when multi-compartment pelvic floor prolapse coexists), pelvic floor physiotherapists, and, in complex cases, urogynaelogical radiologists experienced in dynamic proctographic assessment.

Frequently Asked Questions

Rectal prolapse is a condition in which the full thickness of the rectal wall turns inside out and protrudes through the anal canal. It is distinct from haemorrhoids, which involve only the mucosal lining. Rectal prolapse affects approximately 2.5 per 100,000 people per year in the general population. It predominantly affects women (female-to-male ratio approximately 6:1), with peak incidence in women over 70 years. In younger patients (<40 years), prolapse occurs in both sexes, sometimes associated with neurological conditions, chronic constipation, or pelvic floor connective tissue disorders. Left untreated, external rectal prolapse worsens progressively, causing increasing soiling, incontinence, and psychological distress, and may occasionally become acutely incarcerated requiring emergency surgery.
Approximately 50–70% of patients who have faecal incontinence caused by or worsened by rectal prolapse experience meaningful improvement in continence following rectopexy. The mechanism involves correction of the mechanical stretch injury inflicted on the internal and external anal sphincters by repeated prolapse episodes, restoration of the normal anorectal angle, and improved rectal reservoir capacity. However, incontinence that persists despite successful prolapse repair reflects underlying structural sphincter damage (identified on endoanal ultrasound) or pudendal nerve injury (identified on nerve conduction studies). In these patients, additional measures such as sacral nerve stimulation, sphincter augmentation with injectable bulking agents, or sphincteroplasty may be required. Pre-operative anorectal physiology studies help predict which patients are most likely to achieve continence improvement after rectopexy alone.
Ventral mesh rectopexy (VMR), introduced by Professor Alexander D'Hoore in Leuven, Belgium, differs from posterior rectopexy in that dissection is limited to the anterior rectovaginal (or rectovesical in men) space — the posterior mesorectum and its autonomic nerve supply are not disturbed. A strip of mesh is attached to the anterior rectal wall and fixed to the sacral promontory, providing support without circumferential mobilisation. Compared to posterior rectopexy, VMR is associated with significantly lower rates of worsening constipation (10% vs 30–40%), preserved sexual and bladder function, and equivalent recurrence rates (2–5%). For these reasons, VMR is currently the preferred technique at most specialised pelvic floor centres, particularly for women with multi-compartment posterior prolapse and for patients with pre-existing constipation. The principal ongoing concern is the small risk of mesh-related complications (erosion, infection), which can require mesh removal in 0.5–2% of cases.
Most patients are walking independently and tolerating a normal diet within 24–48 hours of surgery. Discharge from hospital typically occurs at 2–4 days with the bowel functioning. Return to sedentary desk work is usually possible at 2–3 weeks. Driving resumes at 2–3 weeks once the patient can perform an emergency stop without discomfort. Return to physical labour or strenuous activity should wait until 6–8 weeks to protect the healing rectopexy fixation. Heavy lifting (>5 kg) should be avoided for 6 weeks. Pelvic floor physiotherapy beginning at 4–6 weeks and high-fibre dietary habits are maintained long-term to optimise functional outcomes and reduce recurrence risk.
In the United States, laparoscopic rectopexy costs USD 15,000–35,000 for the complete episode of care. At JCI-accredited hospitals in India, the same procedure is available for USD 2,500–6,000; in Thailand, USD 4,000–8,000; in Turkey, USD 3,000–7,000; in Malaysia, USD 4,000–9,000; in Hungary, USD 4,000–8,000. These destinations offer experienced colorectal surgeons, modern laparoscopic equipment, and internationally accredited facilities at 70–85% lower cost than the US. Ventral mesh rectopexy may cost slightly more than suture rectopexy due to mesh implant costs. Robotic rectopexy carries additional platform charges. Confirm with each hospital what is included: surgeon and anaesthesia fees, hospital stay, histopathology, implant, and post-operative follow-up consultations.

References

  1. Tou S, Brown SR, Malik AI, et al. Surgery for complete rectal prolapse in adults. Cochrane Database Syst Rev. 2015;11:CD001758.
  2. Senapati A, Gray RG, Middleton LJ, et al. PROSPER: a randomised comparison of surgical treatments for rectal prolapse. Colorectal Dis. 2013;15(7):858-868.
  3. D'Hoore A, Cadoni R, Penninckx F. Long-term outcome of laparoscopic ventral rectopexy for total rectal prolapse. Br J Surg. 2004;91(11):1500-1505.
  4. Samaranayake CB, Luo C, Plank AW, et al. Systematic review on ventral rectopexy for rectal prolapse and intussusception. Colorectal Dis. 2010;12(6):504-512.
  5. Emile SH, Elfeki H, Shalaby M, et al. Laparoscopic ventral mesh rectopexy versus laparoscopic posterior mesh rectopexy for treatment of complete rectal prolapse: a meta-analysis. Colorectal Dis. 2017;19(12):O424-O434.
Ad — after-content

Medically Reviewed

Our medical content follows strict editorial guidelines to ensure accuracy and reliability.

Up to Date

Last updated: 2026-06-26

Important: This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment.

Ready to take the next step?

Connect with top hospitals and specialists. Get personalized guidance for your medical journey.

Latest from our blog and forum

Latest from Our Blog

View All →

Latest Forum Discussions

View All →
Compare Costs Get Free Help

Medical Disclaimer: The information on MyMedicPlus is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this site.